Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma

BACKGROUND: Current guidelines lack recommendations for the use of immunotherapy and immune-related biomarkers for hepatocellular carcinoma (HCC). We aim to provide reliable evidence of the association of survival with HCC immunotherapy and to demonstrate that genomic mutation signature could be an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Qiyun, Yu, Yunfang, Li, Anlin, Chen, Jie, Yu, Tingting, Xu, Xiaolin, Xie, Xinxin, Chen, Yongjian, Lin, Dagui, Zeng, Qiaohong, Zhang, Yuxin, Tang, Xudong, Yao, Herui, Luo, Baoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154492/
https://www.ncbi.nlm.nih.gov/pubmed/32309377
http://dx.doi.org/10.21037/atm.2020.01.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154492/
https://www.ncbi.nlm.nih.gov/pubmed/32309377
http://dx.doi.org/10.21037/atm.2020.01.32

Ejemplares similares